Hot Life Science Investor Mandate 2: VC fund Seeking Clinical Stage Oncology Opportunities

4 Sep

A VC firm based in the United States is currently investing from its second fund, which had a first close of $36m in 2014 and is targeting a raise of $100m. The firm typically invests $2-5 million. The fimr invests primarily in the USA but is also open to considering opportunities in Canada.

The firm only invests in oncology companies. Within the oncology field, the firm invests in proprietary technologies in therapeutics, diagnostics and devices, and is open to investing in any form of cancer (including rare cancers), but has a preference for investing in large market opportunities. The firm prefers to invest in companies that have attained proof of concept animals and have entered clinical trials in humans

The firm prefer to work with highly qualified, experienced management teams.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: